Pinned Tweet
$NWBO
The miracle of Braelyn
With help from Braelyns mother Amanda, we have made a presentation, that documents Braelyns incredible journey the last 3 years.
Please share.
There is a link to donation site, if you would care to help 🙏
nwbo-community.com/news/15c6…
$NWBO
The Golden Trail
Explore the full map of the UK regulatory agencies events and communication with impact on NWBO's MAA approval of DCVax-L.
nwbo-community.com/news/7571…
$NWBO
People are pondering how there can be selling at this moment in time, with so much good news this week, that it is impossible now, not to expect approval very soon.
I covered it a couple of times. You can read about it here
investorshub.advfn.com/board…
and in former X post below.
Anyone doubting or denying manipulation, are financially incentivized to say so.
nitter.cf/FlemmingBruce/status/1…
$NWBO
Let’s look at how the criminal market makers succeed in pushing down NWBOs share price again and again.
You can push a stock down without first borrowing real shares by using financial side-bets (derivatives), special market-maker “hall passes” (exemptions), and non-US sister companies (offshore affiliates) that slip past Reg SHO’s “you must locate and deliver real shares” checks.
How it’s done — in plain words
• Side-bets instead of shares:
Use options or swaps to bet against the stock. It feels like shorting to the price, but there’s no obvious “borrowed share” to track.
• “IOU” shares as cover:
Hold a convertible note/warrant (an IOU for future shares) and claim you’re hedging. That can delay the “you must deliver real shares now” requirement.
• Temporary hall pass:
Market makers have limited exemptions so they can keep markets moving. Abused, that looks like shorting first, sorting out delivery later.
• Do it from abroad:
Place the position through a foreign affiliate. On paper, the US books don’t show the same short footprint, even though the economic short exists.
• Keep the fail off the radar:
Shuffle positions between accounts or do “reset” trades so fails-to-deliver don’t sit long enough to trigger forced buy-ins.
• Cap the price on the tape:
Throw up thick, fleeting sell walls or print mostly off-exchange/dark, so rallies stall at neat levels (e.g., $0.2999).
Why it can keep working even at a “ridiculously low” price
• Rule gaps + slow enforcement.
The system polices delivery, not every synthetic way to bet down a price.
• Thin markets. On OTC names, small money can move levels.
• Plenty to borrow. Margin accounts and share-lending programs keep feeding inventory.
• Your buys may not hit the lit tape. Internalization/dark routing can mute visible demand.
Stuttgart ≠ offshore loophole (super simple)
• Offshore routing = booking the short through a foreign sister company to dodge US visibility.
• Stuttgart exchange = just another market posting quotes. Buying there can add some pressure (arbitrage), but it doesn’t fix the US routing tricks.
What actually breaks the dam
• Forced buy-ins when fails can’t be rolled anymore.
• Regulator action on spoofing/exemption abuse.
• A big real-world catalyst + overwhelming volume.
• Less lendable float (e.g., fewer margin shares; opting out of lending where possible).
Bottom line:
Price can be pinned without obvious “borrowed shares” by using synthetic bets, exemptions, and foreign affiliates. It lasts until buy-ins, enforcement, or major catalysts overwhelm the setup.
#Flaskworks patent granted on October 8, 2026: 🇦🇺 AU2025201614 - "Dendritic cell generating apparatus and method"
patentscope.wipo.int/search/…
$NWBO
🇩🇰 The Danish Dude 🇬🇱 retweeted
#Flaskworks patent granted on August 26, 2026: 🇰🇷 KR1020217035945 - "Cell culture systems and uses thereof"
patentscope.wipo.int/search/…
$NWB0
$NWBO
I agree. This news is great. It’s huge. It plays directly into the expected scenario of point of care. We’re on the road following the plan.
But it won’t do much good in terms of supporting the share price.
It will stop people normally complaining about the silence, 3-7 days and then they will forget that the company being informative once again had NO IMPACT on the share price.
We are around 3000% below a fair valuation before approval. Don’t waste your life worrying about whether we close above $0.18 or in that ballpark.
As I’ve stated before, this is sheer stock market manipulation and not a situation brought upon the company for being silent.
But unless we get approval before that, we will get complaints in a week about the company not being transparent, instead of accusing market makers rightfully for manipulation and suppression of share price.
Be glad for the news!
It’s excellent …. and now pass the mike to the fudders for some more oral diarrhea.
Replying to @Clurin5841 @FlemmingBruce
To the contrary... This announcement IS "News".
It is simply not "THE" News.
Without approval announcement, next week the SP will go lower than it was 3 days ago.
That's what I mean.
$NWBO
Listen. Look at the trail. Use reason.
It started with APPGBT groups and Linda Powers testimony.
Then came NHS High Cost Drugs List.
Then followed changes to MHRA, NICE and NHS rules and regulations.
Then came point-of-care.
Then came NHS PR, that they work with NWBO.
Coincidences at this level are non existing.
When the UK government is your partner to reach all cancers… will you be surprised when the UK government then approves it … for all cancers? $NWBO
$NWBO
Pop quiz!
What kind of self denigrating fud narrative, would you spout today after yesterdays news about NHS?
And who will initiate stupidity day?
Odds are:
LearningCurve2020 - 60%, posting a link to another potential competitors treatment perhaps coming in 2032 and then posting 5 responses to it, arguing why no one has any comments to it.
FeMike - 25% - having a tantrum while whining over Linda Powerless being the worst CEO in the universe
brazen22 - 15% - trying to rhetorically circumvent former statements of his and make him look wiser that he is, while wondering if he should create another account.
$NWBO
"I have my own rules and adhere to them. The rule is simple but inflexible. A James Stewart picture must have two vital ingredients: it will be clean, and it will involve the triumph of the underdog over the bully."
Speak the truth and ALWAYS side with the good guys.
$NWBO
I would like to watch a chess game with Linda Powers and FeMike.
I've never witnessed check mate in one before.
$NWBO
Being invested in this only takes patience.
Oh ….
$NWBO
Take todays news:
“DCVax®-L – a treatment for Glioblastoma multiforme (GBM), an aggressive form of primary brain cancer, as well as all solid tumours.”
Correlate with NHS high cost drugs list and the indicator changed to CANCER from glioblastoma.
AI says:
This is particularly significant when considered alongside your observation that NHS England's High Cost Drugs List changed Murcidencel's indication from “glioblastoma” to “cancer.”
The distinction is important: NHSBT is publicly describing DCVax-L in the context of all solid tumours, while the current MHRA marketing application concerns glioblastoma.
$NWBO
When exwannabe? Are you serious?
It’s been known for two years.
Today was just the first announcement of what’s to come.
Just wait when Flaskworks is announced.
But hey, you couldn’t even get ATL-DC is DCVax-L right.